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https://doi.org/10.1016/j.stemcr.2018.04.018SUMMARYIn the developing nervous system, neural stem cells are polarized andmaintain an apical domain facing a central lumen. The presence of
apical membrane is thought to have a profound influence on maintaining the stem cell state. With the onset of neurogenesis, cells lose
their polarization, and the concomitant loss of the apical domain coincides with a loss of the stem cell identity. Little is known about the
molecular signals controlling apical membrane size. Here, we use two neuroepithelial cell systems, one derived from regenerating axolotl
spinal cord and the other fromhuman embryonic stem cells, to identify amolecular signaling pathway initiated by lysophosphatidic acid
that controls apical membrane size and consequently controls and maintains epithelial organization and lumen size in neuroepithelial
rosettes. This apical domain size increase occurs independently of effects on proliferation and involves a serum response factor-depen-
dent transcriptional induction of junctional and apical membrane components.INTRODUCTION
Epithelial polarization and organization of a central lumen
is a defining aspect of nervous system formation. During
early vertebrate neurulation the neural plate is formed,
which subsequently undergoes folding to form the neural
tube. At early stages, before and shortly after closure of
the neural tube, the neuroepithelium consists of self-re-
newing, tight-junction-forming neural progenitor cells
(NPCs) whose apical domains all face toward a central
lumen that contains the cerebrospinal fluid. At later stages,
junctional complexes are remodeled; cells lose tight junc-
tions and their polarized morphology, and at the same
time the onset of neuronal differentiation begins (Aaku-
Saraste et al., 1996).
The capability of tight-junction-containing NPCs to
organize into polarized, lumen-containing structures is
also evident during neural organoid formation (Eiraku
et al., 2011;Meinhardt et al., 2014) and in two-dimensional
cultures of mouse embryonic day 8 (E8) primary neural
plate cell explants that spontaneously self-cluster to form
two-dimensional mini-lumina termed ‘‘neural rosettes’’
(Elkabetz et al., 2008). Neural rosettes consist of small
cellular units in which the NPCs all orient their apical
domain to a common lumen-like center. Due to their self-
organizing capacity, neural rosettes can be regarded as
in vitro, two-dimensional versions of the neural tube.Stem Cell R
This is an open access article under the CSimilar to the gradual loss of neural stem cell identity in
the developing neural tube, the ability of neuroepithelial
cell explants derived from E8 mouse embryos to organize
in rosettes is also restricted to a short window of early neu-
ral development prior to a loss of polarization. It has been
difficult to maintain rosettes in culture as they tend to
spontaneously progress toward more differentiated, less
polarized phenotypes (Elkabetz et al., 2008).
An alternative source of rosette-forming, tight-junction-
containing neuroepithelium has been mouse and human
embryonic stem cells (hESCs) early after neural lineage
induction. The early rosette-forming neuroepithelial state
is considered an important state for stem cell differentia-
tion, as it represents the early neural plate or neural tube
stage at which cells have committed to the neural lineage
but are still susceptible to instructive cues that pattern
the CNS along the anterior/posterior and dorsal/ventral
axes (Broccoli et al., 2014; Elkabetz et al., 2008; Li et al.,
2005). In hESCs, dual inhibition of SMAD signaling by
noggin/dorsomorphin and SB431542 efficiently directs
cells along the neural lineage and results in rosette forma-
tion (Chambers et al., 2009; Zhou et al., 2010). However,
upon passaging, cells successively form smaller rosettes in
which cell polarization and tight junctions become
reduced over time until the neuroepithelial cell state is
lost. Elkabetz et al. (2008) reported that addition of SHH
and the Notch signaling agonists Delta and Jagged1 duringeports j Vol. 10 j 1751–1765 j June 5, 2018 j ª 2018 The Author(s). 1751
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Figure 1. Serum and LPA Induce Large Rosette Formation in Cultured Axolotl and Human NPCs
(A) Immunostaining of axolotl- and hESC-derived NPCs for SOX2 (upper panels), and SOX1 and ZO-1 (lower panels) shows induction of large
rosette formation in the presence of serum or LPA. F-actin in axolotl NPCs was stained with Alexa Fluor 647 phalloidin. Scale bars, 200 mm
(upper panels) and 100 mm (lower panels).
(B and C) Immunostaining of hESC-derived NPCs for Nestin, Vimentin, SOX1, SOX2, N-cadherin, aPKC and ZO-1. F-actin was labeled with
Alexa Fluor 488 phalloidin. y-x images represent top view and z-x images side view. Scale bars, 50 mm (B) and 10 mm (C).
(D) Immunostaining of NPCs that have formed enlarged rosettes after 18 hr of exposure to different LPA concentrations (0–22.5 mM) for
SOX1 and ZO-1. Scale bar, 100 mm.
(legend continued on next page)
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plating of rosette-forming NPCs could prolong the rosette-
forming state for approximately four passages by presum-
ably promoting self-renewing cell divisions.
Few studies have identified signaling factors that control
growth and expansion of the luminal neural tube-like area
independent of cell proliferation, and beyond the factors
mentioned above there are no known factors that specif-
ically sustain a large rosette-forming neuroepithelial state.
Identification of factors that can sustain/promote neuroe-
pithelial lumen formation independently of or parallel to
self-renewing divisions should have a profound effect on
propagating the neural rosette-forming state and might
forestall the timely differentiation to later-stage neural
progenitors/committed cells. Interestingly, the sustained
self-renewal of early neuroepithelial cells is a characteristic
feature of spinal cord regeneration in the axolotl, where
spinal cord lesions induce cells to enter the neuroepithelial
state. This state is sustained and self-renews for at least
2 weeks to yield an outgrowth of the severed spinal cord
tube (Rodrigo Albors et al., 2015; Rost et al., 2016).
Given the importance of the tight-junction-containing
early neuroepithelial state during neural tube formation/
regeneration in the axolotl, we sought to identify a molec-
ular factor that promotes expansion of the apical lumen in
neuroepithelial rosette cells. Here we have identified lyso-
phosphatidic acid (LPA) as a molecule that can cause an
expansion of the apical domain of axolotl and human
NPCs and a growth of the rosette luminal area independent
of cell proliferation. Continuous treatment of hESC-
derived NPCs with LPA yields the propagation of the
rosette-forming state for at least 52 passages. Correspond-
ingly, we see a suppression of neuronal differentiation
and sustenance of the SOX2+, proliferative state. LPA acts
through Rho and serum response factor (SRF) to promote
upregulation of tight-junction actin-related- and apically
associated proteins.RESULTS
Addition of Serum or LPA to Axolotl and HumanNPCs
Induces Rosette Enlargement
Axolotl spinal cord regeneration is a unique system in
which an injury-initiated wound response induces the
self-renewal and expansion of NPCs that grow a lumen-
containing neural tube, which can recapitulate neural(E and F) Quantification of the frequencies of the apical rosette lum
different LPA levels. Red dots indicate individual apical rosette lume
mation (F).
(G) Mean number of rosettes ± SEM per analyzed image. Statistical a
posteriori test. *p < 0.05, n = 3 independent experiments.
All nuclei were labeled with Hoechst 33342. See also Figures S1 andpatterning (Rodrigo Albors et al., 2015; Walder et al.,
2003). A key extracellular mediator of the injury response
is serum. In studies of limb regeneration two serum compo-
nents, BMP4/7 and PDGF, were shown to induce prolifera-
tion (Wagner et al., 2017) and cell migration (Currie et al.,
2016). We therefore asked whether serum and any of its
major components could induce an expansion of neuroe-
pithelial rosette formation in cultured axolotl spinal cord
cells. While the two-dimensional neural rosettes do not
represent closed lumina, they still represent neural tube-
like structures that recapitulate many features of a true
lumen and thus can be used to identify factors affecting
lumen organization. We exposed axolotl spinal cord-
derived SOX2+ NPCs to a 3-day pulse of serum. Strikingly
we observed the organization of the cells into larger rosette
structures over time (Figure 1A, upper left and middle
panels). To identify the serum component responsible for
this effect, we assayed LPA,which is amajor signaling phos-
pholipid in serum. When we exposed cells to concentra-
tions of LPA in a similar range compared with those
measured in serum (Yung et al., 2014), we recapitulated
the larger rosette phenotype similar to the phenotype
observed with serum treatment (Figure 1A, upper right
panel). We concluded that LPA is a serum-borne signaling
molecule that can induce rosette enlargement in axolotl
spinal cord NPCs. We next asked whether the action of
LPA represents a conserved signaling pathway that can
regulate rosette lumen size in other vertebrate neuroepithe-
lia. We therefore tested whether serum and LPA induced an
increase in rosette size in hESC-derived NPCs. We imple-
mented a modified version of a three-dimensional dual
SMAD signaling inhibition neural differentiation protocol,
which efficiently converted hESCs into small rosette-form-
ing SOX1+ NPCs (Khattak et al., 2015) (Figures 1A [lower
left panel] and S1). Upon incubation with serum or LPA,
the humanNPCs reorganized to form larger rosettes within
18–24 hr, indicating that the signaling pathway leading to
larger rosette structures is conserved between axolotl and
human NPCs (Figure 1A, lower middle and right panels).
Human NPCs Express Early NSC Markers and Exhibit
Apical to Basal Polarity
Rosette NPCs are considered to represent a neural stem cell
(NSC) type whose lumen-organizing capacity and neuroe-
pithelial marker expression strongly resembles early neuro-
epithelium at the neural plate stage (Elkabetz et al., 2008; Lien size areas in mm2 and the number of SOX1+ cells per rosette at
n sizes (E) and number of SOX1+ cells participating in rosette for-
nalysis was performed using an ANOVA test followed by Tukey’s a
S2.
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et al., 2005). We characterized the human neural rosettes
with respect to their neuroepithelial marker expression.
Both control small rosette and LPA-induced large rosette
NPCs expressed the intermediate filament proteins Nestin
and Vimentin and the neuroectodermal transcription fac-
tors SOX1 and SOX2. Consistent with their ability to orga-
nize a lumen-like structure, the NPCs in both conditions
expressed the apically localized proteins ZO-1, N-cadherin,
atypical protein kinase C (aPKC), CD133 and showed en-
riched localization of F-actin at their apical side (Figures
1B, 1C, and S2). While control and LPA-treated NPCs ex-
pressed similar neuroepithelial and polarity markers, we
observed striking differences in the spatial organization
of the cells. In control rosettes the lumen exhibited a
strongly constricted morphology with clustering of the
ZO-1 signal into a defined point (Figure 1C, lower andmid-
dle left panels). In contrast, in the presence of LPA the
luminal surface became much larger and cells adopted an
unconstricted morphology in which the individual cell-
cell junctions were easily recognizable by staining for
ZO-1 (Figure 1C, lower and middle right panels).
LPA Increases Lumen Size in a Concentration-
Dependent Manner in Human Neural Rosettes
We further assessed whether the LPA-induced rosette size
increase could be regulated by incubating the cells with
different LPA concentrations. Exposure of NPCs to
different LPA doses over a period of 18 hr resulted in the for-
mation of larger rosettes with larger luminal surfaces in a
concentration-dependent manner (Figure 1D). We defined
the lumen surface area as the entire ZO-1-positive area
completely enclosed by SOX1+ nuclei. Quantification
revealed that distributions of apical rosette lumen area are
shifted toward larger values. In particular, lower quartiles,
upper quartiles, and interquartile ranges monotonically
increase from 59.4, 101.6, and 42.2 mm2 to 64.1, 760.9,
and 696.9 mm2, respectively, in response to 22.5 mM LPA
(Figure 1E). We next quantified the number of SOX1+ cells
per rosette. Analogously with rosette lumen area, lower
quartiles, upper quartiles, and interquartile ranges mono-
tonically increase from 24, 40, and 16 to 50, 134, and 84
cells, respectively (Figure 1F). Concomitant with the in-
crease in rosette size, the total number of rosettes per image
decreased from a mean of 508 ± 39 to 106 ± 15 rosettes
(Figure 1G).
Human NPCs Can Form Large Rosettes in the Absence
of Cell Proliferation
We next investigated whether the LPA-mediated increase
in lumen size was a consequence of increased proliferation.
Depending on the cell origin and the culturing conditions,
hESC-derived and induced pluripotent stem cell (iPSC)-
derived NPCs have been reported to either increase or1754 Stem Cell Reports j Vol. 10 j 1751–1765 j June 5, 2018decrease their proliferation in response to LPA (Frisca
et al., 2013; Hurst et al., 2008; Pebay et al., 2007).
We measured proliferation in response to LPA concentra-
tions ranging from 0.5 mM to 2.5 mM by quantifying the
percentage of 5-ethynyl-20-deoxyuridine (EdU)+/SOX1+
cells, which revealed a 66% increase in the proliferative
activity ofNPCs thatwere exposed to 0.5 mMLPA compared
with the control. Concentrations higher than 0.5 mM did
not further significantly increase proliferation (Figures 2A
and 2B).
To test whether cells could form larger rosettes in the
absence of proliferation, we blocked proliferation with
the S-phase inhibitor hydroxyurea (HU). NPCs were pre-
treated for 12 hr with HU prior to LPA exposure (Figures
2C and 2D). After HU pretreatment, none of the cells
showed EdU incorporation and LPA was added to the
NPCs. Non-proliferative NPCs exposed to LPA still signifi-
cantly increased their apical rosette lumen area from a
mean size of 57 ± 1 mm2 to 131 ± 7 mm2. Control cells
that were still proliferative responded to LPA with even
larger rosette formation (206 ± 20 mm2) (Figures 2E and
2F). NPCs undergo interkinetic nuclear migration. During
M phase the nuclei localize toward the apical site whereas
during S phase they are located more basally. Kingsbury
et al. (2003) reported that nuclei of LPA-exposed ventricu-
lar zone (VZ) NPCs that were cultured in mouse E14
cerebral cortices showed displacement toward more basal
regions during M phase. However, in our case immuno-
staining of NPCs for the mitotic marker pH3 and quantifi-
cation of the distance from the apical lumen site toward the
center of the surrounding pH+ nuclei did not significantly
change the position of M-phase nuclei between both
conditions (Figure S3).
LPA Induces Apical Domain Enlargement of Human
NPCs
To understand the changes in epithelial organization that
lead to large rosette formation of NPCs, we examined
rosette organization at different times after exposure of
cells to 15 mM LPA. Prior to LPA exposure the NPCs were
organized in small rosettes. ZO-1 could be detected at
the constricted apical cell sides, which enclosed a small
lumen (Figures 3A and 3B, 0 hr). Two hours after LPA
administration the apical domains had slightly expanded
in width (Figures 3A, 3B, and 2H). After 10 hr, the NPCs
had organized in a large and connected neuroepithelial-
like cell layer in which the apical domains had adopted
a much broader and unconstricted morphology (Figures
3A and 3B, 10 hr). After 18 hr of exposure to LPA, the api-
cal domain areas started to shrink and appeared more
constricted. At this point, the entire morphology rather
resembled a cone-shaped large rosette structure than a
large, connected, and flat neuroepithelium (Figures 3A
Figure 2. Cell Proliferation Is Not Required for Large Rosette Formation in Human NPCs
(A) EdU incorporation in NPCs in response to LPA. EdU signal (green) and immunofluorescence for SOX1 (red) show robust incorporation of
EdU. Scale bar, 100 mm.
(B) Quantification of EdU+/SOX1+ cells. Data represent mean ± SEM, ANOVA test followed by Tukey’s a posteriori test. *p < 0.05, n = 3
independent experiments.
(C) Scheme depicting the experimental setup of the cell proliferation block experiment shown in (D) and (E).
(D) NPCs were cultured for 12 hr in normal culturing medium () or in medium supplemented with 0.5 mM hydroxyurea (HU) (+). EdU signal
(green) and immunofluorescence for SOX1 (red) and ZO-1 (white) show reduced EdU incorporation after HU treatment. Scale bar, 100 mm.
(E) Rosette formation in the absence of proliferation. NPCs were cultured in normal culturing medium (left panels), medium supplemented
with 22.5 mM LPA (middle panels), or medium supplemented with 22.5 mM LPA and 0.5 mM HU (right panels). EdU signal (green) and
immunofluorescence for SOX1 (red) and ZO-1 (white). Scale bar, 100 mm.
(F) Quantification of mean apical rosette lumen surface area. ANOVA test followed by Tukey’s a posteriori test. Data represent mean of
medians ± SEM. *p < 0.05, n = 3 independent experiments.
Prior to fixation, NPCs were incubated for 45 min with EdU (30 mM). Nuclei were labeled with Hoechst 33342 (blue). See also Figure S3.
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and 3B, 18 hr). At 24 hr after LPA addition, the cells had
completely reverted to the constricted small rosette state
(Figures 3A and 3B, 24 hr). The observations indicate
that LPA dynamically regulates the epithelial organization
of NPCs within 24 hr. The fact that the neuroepithelial-
like morphology of the NPCs, which was observed 10 hr
after LPA administration, reverted over time to smaller
rosettes, suggested that LPA may not be stably maintained
in the culture media over time. To investigate whether the
LPA activity (15 mM) is reduced within 10 hr to a level
insufficient to induce a neuroepithelial-like phenotype
in NPCs de novo, we exposed NPCs for 10 hr to 15 mM
LPA and then transferred this medium to a new culture
of NPCs that had not been previously exposed to LPA.
The first NPC culture revealed a strong increase in the neu-
roepithelial-like morphology, with a mean apical area of
16 ± 2 mm2 per cell in LPA-treated NPCs compared with
a mean apical area of 5.3 ± 0.4 mm2 in control NPCs (Fig-
ures 3C [upper panels] and 3D). In contrast, the secondary
NPCs that had been treated with medium from the first
NPCs did not form larger rosettes in response to the media
and only exhibited a mean apical area of 4.9 ± 0.7 mm2
(Figures 3C [middle panels] and 3D). LPA-containing me-
dium that had been exposed for 10 hr to NPCs and that
had been supplemented with new LPA significantly
induced a larger neuroepithelial-like phenotype with a
mean apical area of 12.4 ± 0.7 mm2 per cell (Figures 3C
[lower panels] and 3D). The data show that LPA promotes
the organization of NPCs into a large neuroepithelial-like
cell layer as long as its activity within the medium is
high and does not fall below a certain threshold (Figure 3B,
dashed line). These data also show that LPA activity
(15 mM) in the culture medium is reduced over a period
of 10 hr to a level insufficient to induce rosette
enlargement.Figure 3. LPA Dynamically Regulates the Epithelial Organization
(A) Immunostaining of NPCs that were fixed at different time points a
view and z-x images side view. Scale bars, 10 mm.
(B) Scheme depicting the changes in the epithelial organization of the
LPA activity. Dashed line indicates the critical LPA activity inside th
neuroepithelial-like state. Immunostaining shows NPCs that have ado
Scale bar, 50 mm.
(C) Upper panels: NPCs incubated with 0.5 mL of medium (left) or m
exposed for 10 hr to medium in which NPCs had already been cultivate
with LPA (right). Lower panels: NPCs exposed to culture medium for 10
supplemented with new LPA. Immunostaining of NPCs for SOX1 (red)
(D) Quantification of the mean apical area per cell in mm2. Data repre
using an ANOVA test followed by Tukey’s a posteriori test. *p < 0.05,
(E and F) Immunostaining of NPCs for SOX1 and ZO-1 showing that NP
concentrations. (E) y-x images represent top view and z-x images sid
(G) Quantification of cellular apical domain size in mm2. ANOVA te
medians ± SEM. *p < 0.05, n = 3 independent experiments.
Nuclei were stained with Hoechst 33342. See also Figure S4.LPA Increases Apical Domain Size of HumanNPCs in a
Concentration-Dependent Fashion
The previous findings prompted us to investigate whether
NPC apical domain size has a dose-dependent relation to
the LPA concentration to which the cells are exposed. We
employed a protocol whereby we exposed NPCs to stable
LPA concentrations ranging from 0.3 to 20 mM for 36 hr
to allow enough time for the cells to respond to LPA
(see Supplemental Experimental Procedures). Immunoflu-
orescence of the cells showed that the size of the apical
domains, quantified as the areas of low ZO-1 signal inten-
sity in between the cell-cell borders, concomitantly
increased with increasing LPA concentrations. As a conse-
quence of the apical expansion, small rosettes opened up
their constricted morphology, and NPCs of adjacent
rosettes started to connect their apical domains and fused
into a larger connected epithelial cell layer (Figure 3E).
Quantification revealed a significant increase in the
average apical domain size per cell with increasing LPA
concentrations (Figures 3F and 3G). Analysis of the de-
pendency of apical domain size on the LPA concentra-
tions was performed by a two-state model (see Supple-
mental Experimental Procedures). From the results we
concluded that a primary effect of LPA on the NPCs is
the increase in apical domain area, where 50% of the
maximal area can be achieved at 0.76 mM LPA, a concen-
tration in the range of physiological LPA concentrations
present in serum. Taken together, our results indicate
that the single application of LPA leads to an early expan-
sion of apical domains and the fusion of small rosettes
into a connected cell layer. As LPA is depleted from the
media and apical domains start to shrink, cells segregate
into rosettes that shrink in lumen area over time. The
duration of the flat neuroepithelial state and the onset
of the reversion back to the large and then small rosetteand Increases Apical Domain Size of Human NPCs
fter LPA administration for SOX1 and ZO-1. y-x images represent top
NPCs over a period of 24 hr. Triangle (left side) indicates decreasing
e medium required to maintain the NPCs in a large apical domain-
pted a large neuroepithelial-like morphology after LPA treatment.
edium supplemented with 15 mM LPA (right). Middle panels: NPCs
d for 10 hr and that was either without LPA (left) or supplemented
hr in which NPCs had already been cultivated for 10 hr and that was
and ZO-1 (white). Scale bar, 50 mm.
sent mean of medians ± SEM. Statistical significance was analyzed
n = 3 independent experiments.
Cs exhibit different apical domain sizes in response to different LPA
e view. Scale bars, 10 mm (E) and 100 mm (F).
st followed by Tukey’s a posteriori test. Data represent mean of
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Figure 4. LPA Upregulates Genes Involved in Cell Junction, Actin Cytoskeleton, and PlasmaMembrane Organization in Human NPCs
(A) Scheme illustrating potential important cellular processes involved in apical expansion of epithelial cells. Immunostaining depicts the
small rosette state (left) and the large apical domain morphology of NPCs (right). Scale bar, 10 mm.
(B) Microarray analysis of control NPCs versus LPA-treated NPCs at 2 hr, 10 hr, and 24 hr after initial LPA administration. Graph depicts
expression levels of all genes that show at least an upregulation of more than 2-fold in at least one of the three time points (log2 scale).
(legend continued on next page)
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state can be shortened or extended by simply incubating
the cells with lower or higher LPA concentrations, as
demonstrated in Figure S4.
Apical DomainWidening of HumanNPCs in Response
to LPA Is Transcription Dependent
Apical expansion and the arrangement of epithelial cells
into a large and connected cell layer would be expected to
result from increased lipid incorporation into the plasma
membrane, growth and stabilizationof the underlying actin
cortex, and remodeling of cell junctions (Figure 4A) (Lusch-
nig and Uv, 2014; Yeaman et al., 2004). To understand the
molecular changes associated with apical domain widening
of NPCs, we performed a microarray analysis whereby we
compared the gene expression of small rosette NPCs versus
LPA-treated large rosette NPCs at 2 hr, 10 hr, and 24 hr after
initial exposure to LPA. Examination of all genes that
showed an upregulation of at least 2-fold in one of the three
time points revealed that most upregulation occurs at 10 hr
and reverts to normal gene expression levels at 24 hr, prob-
ably due to decreasing LPA activity within themedium (Fig-
ure 4B).Wewonderedwhether the strong induction of gene
expression in the first 10 hr was crucial for apical domain
widening, so we exposed NPCs to LPA and actinomycin D
(ACTIND), a small molecule commonly used to block RNA
synthesis. NPCs treated with LPA and ACTIND maintained
a small rosette morphology that was not significantly
different from control NPCs or control NPCs treated with
ACTIND (Figures 4C and 4D).
LPA Upregulates Genes Involved in Apical Membrane,
Cell Cortex, and Tight-Junction Function in Human
NPCs
We used DAVID Bioinformatics software to identify
cellular component gene ontology terms (GO_CC terms)(C) Immunostaining of NPCs for ZO-1 and SOX2 that were cultured wi
(Sigma-Aldrich, cat. no. A9415). Scale bar, 50 mm.
(D) Quantification of the mean apical area per cell in mm2.
(EJ) Functional annotation clustering of all genes upregulated more
exhibiting the lowest p value and highest enrichment of upregulated
using DAVID software. Cluster 1 = cell junction formation (E), Cluster
Cluster 4 = membrane-vesicle interactions (H), Cluster 5 = membran
receptor interactions (J).
(K–M) Tables showing strongly upregulated genes (>2-fold) in resp
membrane (L), and actin cytoskeleton (M) organization.
(N) Immunostaining of NPCs for ZO-1 and SRF showing the upregulat
(O) Immunostaining of NPCs for SOX1 and ZO-1 showing the involve
inhibitor (Tocris, cat. no. 1254); CCG-1423, inhibitor of SRF-associate
50 mm.
(P) Quantification of the apical area per cell in mm2.
Statistical significance in (D) and (P) was analyzed using an ANOVA te
experiments. Data represent mean of medians ± SEM. All nuclei wereenriched with genes that were up- or downregulated
more than 2-fold in the microarray, respectively. We
then performed a functional annotation clustering of
the GO terms. Ordering of clusters according to their over-
all p value revealed that the top clusters were highly
enriched in genes related to cell junction formation (clus-
ter 1), plasma membrane (cluster 2), actin filament assem-
bly (cluster 3), membrane-vesicle interactions (cluster 4),
membrane movement and cell migration (cluster 5), and
plasma membrane-receptor interactions (cluster 6) (Fig-
ures 4E–4J). Among the upregulated genes that were
enriched in the six top GO clusters we found many genes
related to the functions required to generate apical mem-
brane, including actin-filament assembly-, cell junction-,
plasma membrane-, and vesicle-associated genes. RNA
expression levels of genes encoding for tight-junction-
associated proteins of the claudin family (CLDN1, 4, 6,
23) were strongly upregulated (Furuse, 2010) (Figure 4K).
Furthermore, RNA expression levels of genes that are
translated into caveolins 1–3 (CAV1–3), which are
involved in trafficking cholesterol-rich membranes that
are enriched in the apical and basolateral surface, were
highly induced, as well as the expression of other genes
involved in apical vesicle trafficking and fusion, such as
syntaxin 3 (STX3) and annexin A2 (ANXA2) (Martin-Bel-
monte et al., 2007; Scheiffele et al., 1998; Sharma et al.,
2006) (Figure 4L). The apical surface is also characterized
by a strong accumulation of cortical actin and correspond-
ingly, a strong upregulation of actin (ACTA1) and actin-
organizing and -stabilizing genes, such as profilin 1
(PFN1), actinin alpha 1 (ACTN1), cortactin (NF2), ezrin
(EZR), and spectrin b5 (SPTBN5) could be detected
(Liem, 2016; Saarikangas et al., 2010) (Figure 4M). GO
analysis of genes that were downregulated by LPA
(>2-fold) mainly resulted in GO clusters related tothout LPA, with LPA, or in the presence of LPA and actinomycin D
than 2-fold at 10 hr after LPA administration. The six top GO clusters
genes from the microarray are depicted. Clustering was performed
2 = plasma membrane (F), Cluster 3 = actin filament assembly (G),
e movement and cell migration (I), Cluster 6 = plasma membrane-
onse to LPA, which are associated with cell junction (K), plasma
ion of SRF in response to LPA. Scale bar, 100 mm.
ment of ROCK and SRF in apical expansion of NPCs. Y-27632, ROCK
d gene transcription (Sigma-Aldrich, cat. No. SML0987). Scale bar,
st followed by Tukey’s a posteriori test. *p < 0.05, n = 3 independent
stained with Hoechst 33342. See also Figures S5A and S5B.
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projections, axons, synapses, and calcium channels of
neurons, indicating a bias in affected cellular components
between the up- and downregulated genes (Tables S1
and S2).
Rho/SRF Signaling Is Involved in the Formation of a
Larger Neuroepithelial-like Morphology of Human
NPCs
LPA has been shown to exert many of its various cytoskel-
etal effects by activation of the Rho signaling pathway and
the downstream transcription factor SRF, which are major
regulators of actin dynamics (Hurst et al., 2008; Miano
et al., 2007). We next investigated whether Rho/SRF
signaling controls apical expansion and the adoption of a
larger neuroepithelial-like morphology in NPCs. Immuno-
staining for SRF revealed a much stronger signal in LPA-
treated NPCs than in control NPCs, indicating that SRF is
upregulated in the presence of LPA (Figure 4N). We next
tested CCG-1423, an inhibitor of SRF-driven gene expres-
sion, and Y-27632, an inhibitor of the Rho downstream
kinase ROCK, on NPCs exposed to LPA. Application of
both inhibitors in addition to LPA resulted in a strongly
disrupted ZO-1 expression pattern compared with NPCs
that were treated with LPA alone (Figure 4O). Quantifica-
tion of the apical area confirmed a significant decrease
per cell from 13. ± 0.5 mm2 in the LPA-treated NPCs toward
9 ± 1 mm2, 6.8 ± 0.3 mm2, and 4.2 ± 0.4 mm2 apical area in
NPCs that were additionally incubated with CCG-1423,
with Y-27632, or without LPA (control), respectively (Fig-
ure 4P). LPA also activates Ca2+-dependent signaling path-
ways in NPCs of the developing brain that influence many
cellular processes (Dubin et al., 2010). To test the impor-
tance of calcium signaling in apical expansion, we applied
the inhibitors edelfosine (blockage of phospholipase C),
2-APB (blockage of inositol triphosphate receptors),
BAPTA-AM (depletion of intracellular Ca2+ levels), and
EGTA (depletion of extracellular Ca2+ levels) to NPCs in
the presence of LPA. The quantification of the apical area
showed that exposure to 2-APB and edelfosine resulted in
significantly decreased apical areas within the 5 hr of incu-
bation time, where no toxic effects of the inhibitors were
observed at the concentrations we employed (Figures S5A
and S5B).
Maintenance of Apical Domain-Forming Capacity in
Human NPCs over 52 Passages
We next investigated whether NPCs maintained their
inducibility by LPA at different passage numbers. Under
normal culture conditions, NPCs at RP1 or RP2 formed
very large rosettes in response to LPA. However, at RP3
the ability of the cells to adopt a large rosette morphology
decreased and at RP4 the cells did no longer formed large
rosettes in response to a 1-day pulse-treatment of LPA1760 Stem Cell Reports j Vol. 10 j 1751–1765 j June 5, 2018(Figure 5A). Based on these results, we tested whether a
continuous exposure of NPCs to LPA could maintain the
competence to form large rosettes. We cultured NPCs
from RP1 with a continuous exposure to 1–2 mM LPA
(see Supplemental Experimental Procedures). Continuous
exposure to this level of LPA yielded SOX2+ cultures with
strongly expanded cellular apical domains and a large
rosette morphology. The maintenance of apical domain
expansion was preserved over 52 passages (Figures 5B
and S5C).
LPA Prevents Neuronal and Glial Differentiation in
Early-Stage and Long-Term LPA-Treated Human NPCs
We further tested whether the maintenance of a large api-
cal domain NPC phenotype yielded reduced neuronal and
glial differentiation of the NPC cultures. We exposed
NPCs for 3 days to constant levels of 0.5 mM LPA (see Sup-
plemental Experimental Procedures) and investigated the
neuronal differentiation rates. Compared with control
small rosette NPCs, the cells supplied with LPA exhibited
broad apical domains with an even ZO-1 distribution (Fig-
ure 5C, upper panels). Immunostaining for the neuronal
markers TUBB3 and HuC/HuD and quantification of
HuC/HuD+ cells revealed that 3.9% ± 0.5% of the cells
from the control expressed HuC/HuD, whereas 0.9% ±
0.2% of the LPA-treated NPCs showed expression (Figures
5C [middle panels], 5D, and S5D). LPA has been reported
to increase apoptosis in hESC-derived neurospheres
(Frisca et al., 2013). To exclude the possibility that the
reduced neuronal differentiation rates were a conse-
quence of an LPA-stimulated increase in apoptosis in
the developing neurons, we determined the percentage
of HuC/HuD+ cells that co-expressed the apoptotic
marker caspase-3 (CASP3). Quantification of the HuC/
HuD+/CASP3+ cells did not reveal a significant difference
in the apoptotic rates between control NPCs and LPA-
treated NPCs (Figures 5C [middle panels] and 5E). We
next assessed whether LPA exposure also prevents the
transformation of NPCs toward a radial glial phenotype.
Control cells cultured for 22 passages displayed high
levels of glial fibrillary acidic protein (GFAP) immunoflu-
orescence signal while NPCs cultured for 22 passages in
medium continuously supplemented with LPA (see Sup-
plemental Experimental Procedures) had a markedly
reduced GFAP immunofluorescence intensity, represent-
ing a 92% decreased signal (Figures 5C [lower panels]
and 5F). Finally, we asked whether NPC cells that had
been cultured long term in LPA retain their neuronal dif-
ferentiation potential. LPA-treated RP14 NPC cultures
were deprived of LPA for 5 days and examined for markers
of neuronal differentiation. 19% ± 1% of cells expressed
HuC/HuD and had mean TUBB3+ areas of 47 ± 5 mm2
per cell, values that were in the range of non-LPA-treated
Figure 5. Constant LPA Exposure Main-
tains the Large Rosette Formation Capac-
ity of Human NPCs
(A) Immunostaining of untreated or LPA-
treated NPCs at different passaging numbers
for SOX1 and ZO-1. Contrast for ZO-1 signal
is enhanced in upper left image. Scale bar,
100 mm.
(B) NPCs that have constantly been cultured
without or with LPA for 26 passages show
different rosette sizes. Immunofluorescence
of NPCs for SOX1 (red) and ZO-1 (white).
Scale bar, 100 mm.
(C) LPA prevents neuronal and glial differ-
entiation without an increase in apoptosis.
Immunostaining of NPCs for SOX1 (red),
SOX2 (red), ZO-1 (white), HuC/HuD (white),
GFAP (white), and CASP3 (green). Scale
bars, 50 mm.
(D) Quantification of the percentage of
HuC+/HuD+ cells.
(E) Quantification of HuC+/HuD+/CASP3+
double-positive cells.
(F) Quantification of the average GFAP in-
tensity (a.u.) per cell.
(G) LPA exposure does not impair differen-
tiation potential of NPCs. Cells passaged for
14 passages in LPA were either maintained
in LPA (+LPA) or deprived of LPA for 5 days
(LPA removed) and assayed for neural dif-
ferentiation. Immunostaining of NPCs for
SOX2 (red), TUBB3 (white), HuC/HuD
(white), and ZO-1 (white). Scale bar, 50 mm.
(H and I) Quantification of the percentage
of HuC+/HuD+ cells (H) and the mean
TUBB3+ area per cell in mm2 (I).
For (D), (E), (F), (H), and (I), statistical
significance was analyzed using a t test.
*p < 0.05, n = 3 independent experiments.
Data represent mean of medians ± SEM.
Nuclei were stained with Hoechst 33342.
See also Figures S5C and S5D.
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cells (HuC/HuD, 11% ± 1%; TUBB3+ area/cell, 51 ±
4 mm2) and higher than cells that had been continuously
exposed to LPA (HuC/HuD, 3.9% ± 0.2%; TUBB3+
area/cell, 3 ± 1 mm2) (Figures 5G–5I). These results indi-
cate that propagation of rosette-forming neuroepithelia
using LPA does not compromise their differentiation
potential compared with controls.DISCUSSION
Rosette-forming NPCs are considered to represent a very
early-stage NSC type that can differentiate into diverse
neuronal and glial subtypes (Broccoli et al., 2014; Kriks
et al., 2011). Unfortunately the rosette state could not pre-
viously be maintained for many passages. So far only few
factors, such as SHH and Notch signaling agonists, have
been identified that are able to maintain a rosette pheno-
type in cultured NPCs for up to four passages presumably
by promoting self-renewing cell divisions. In addition,
Koch et al. developed a protocol whereby NPCs could be
passaged for >150 passages in the presence of fibroblast
growth factor 2 (FGF2) and epidermal growth factor
(EGF) without losing a small rosette phenotype and
neuronal differentiation potential (Elkabetz et al., 2008;
Koch et al., 2009). Here we identify LPA as a serum factor
that has amajor effect on the expansion of the apicalmem-
brane of cultured axolotl and humanNPCs, resulting in the
formation of very large rosette structures, which in the case
of humanNPCs can bemaintained for at least 52 passages if
constantly supplied with LPA. Large rosette formation of
human NPCs occurs irrespective of cell proliferation but
is rather a consequence of apical domain expansion and
concomitant with the opening up of existing small rosettes
and their fusion into larger epithelial cell clusters. The
long-term LPA-treated human NPCs are competent in un-
dergoing neuronal and glial differentiation once LPA is
withdrawn from the medium. In former publications LPA
has been shown to prevent neuronal, but not glial, differ-
entiation of hESC- and iPSC-derived plated neurospheres
(Dottori et al., 2008; Frisca et al., 2013). Using our protocol
we show that long-term LPA exposure prevents both
neuronal and glial differentiation in NPCs. The opposing
results could be due to differences in the culturing proto-
cols and the timing of LPA treatment. In the future it will
be interesting to assess whether long-term LPA-cultured
NPCs can also yield differently patterned neuronal
subtypes.
Another very interesting phenotype is the LPA-mediated
expansion of the apical domain of NPCs itself. Few mole-
cules have been shown to regulate apical domain size in
epithelial cells. Deregulation of components of the Hippo
signaling pathway, such as knockdown of the scaffolding1762 Stem Cell Reports j Vol. 10 j 1751–1765 j June 5, 2018protein KIBRA or expression of the CDC42 activator
DBL3, can lead to apical expansion in MDCK cells. Also,
overexpression of the protein Crumbs resulted in an apical
expansion of Drosophila embryonic epithelia (Wodarz
et al., 1995; Yoshihama et al., 2011; Zihni et al., 2014). In
our microarray we could not detect significant changes in
the expression levels of the involved Hippo signaling com-
ponents or Crumbs, implying that apical expansion in
NPCs might be mediated by a different mechanism.
Indeed, we could identify top GO term clusters and
strongly induced genes related to cell junction-, actin-,
and plasma membrane-related cellular processes, which
have been described as important processes during the
luminogenesis of epithelial tissues (Datta et al., 2011;
Luschnig and Uv, 2014). In the future, knockout studies
will need to be performed to identify the key genes that
promote apical expansion.
Binding of LPA to most of its receptors activates the Rho
signaling pathway and the associated downstream factors
ROCK1 and SRF (Hurst et al., 2008; Miano et al., 2007).
In our experiments we also observed a strong dependency
of large apical domain formation on ROCK1 and SRF.
A literature-based metacore analysis of all SRF target genes
revealed a total of 439 binding targets, among which 105
target genes were found to be up- or downregulated
(>2-fold) in our microarray data, while most of the upregu-
lated genes were found to be transcriptional activators
(Table S3 and Figure S5E). The fact that around 25% of all
SRF target genes exhibited differential gene expression in
response to LPA suggests an important role for SRF inmedi-
ating apical expansion. In addition, we do not exclude that
activation of the Ca2+ signaling pathway by LPA plays an
important role in conveying apical expansion, since
blockage of phospholipase C and IP3R Ca2+ channels by
pharmacological inhibitors could also reduce apical expan-
sion. Both signaling pathways could act in combination to
promote expansion of the apical domain.
Kingsbury et al. (2003) observed the formation of gyri
and an increased cortical thickness when they cultured
E14 brain sections of the mouse telencephalon in an
in vitro slice culture system in the presence of LPA. Growth
in cortical size was attributed to a larger NPC pool and
increased terminal neuronal cell divisions. However, those
phenotypes could hardly explain gyri formation, and it was
suggested that other LPA-initiated signaling pathways
might cause the folding. In our system we can also observe
the formation of a large pseudostratified rosette neuroepi-
thelium, which also contains strongly folded regions that
resemble gyri. In this regard it is tempting to speculate
whether an expansion of the apical domain of the NPCs
close to the VZ could increase the total apical surface of
the VZ, which could lead to more apical tension or a rear-
rangement of cells and provide a stimulus for the folding.
Hence it would be interesting to find out whether folding
of mouse brain cortices in the presence of ROCK or SRF
inhibitor would be impaired.
During development, many future lumen-containing
epithelial tissues, such as pancreatic or kidney tissue,
form rosettes as intermediate structures during lumen
morphogenesis. The rosettes then fuse with each other to
create larger tubular structures (Harding et al., 2014). As
LPA promotes the fusion of adjacent small rosettes into
larger luminal structures in our system, it will also be
tempting to test whether LPA can promote the organiza-
tion of other rosette-forming epithelial tissues into larger
luminal structures.EXPERIMENTAL PROCEDURES
Axolotl NSC Culture
Axolotl spinal cord explantswere dissociated into single cells using
PBS/EDTA and plated on 12-well plates coated with gelatin at a
density of 32,000 cells/cm2. Cells were passaged every 3 weeks
and cultured in DMEM/F-12 medium supplemented with human
FGF2 and B27 (Gibco). For large rosette induction, the culture
mediumwas supplemented for 3 days with either 30% fetal bovine
serum or 20–50 mMLPA 1 day after passaging with a daily medium
change. After 3 days of serum or LPA treatment, cells were cultured
for another 25 days in normal culturing medium to allow for large
rosette formation.hESC Culture and Neural Differentiation
For hESC culture, the hESC lines H9 and H1 were used (WA09,
WA01; WiCell). hESCs were cultured as described previously
(Zhu et al., 2013). Neural differentiation was performed according
to a modified version of published protocols (Khattak et al., 2015).
hESC clumps were cultured for 5 days in low-attachment well
plates in the presence of mTeSR1 medium (STEMCELL Technolo-
gies), supplemented with 2 mM dorsomorphin (Sigma-Aldrich,
cat. no. 5499) and 10 mM SB431542 (Tocris, cat. no. 1614). Under
floating conditions the cell clumps formed embryoid bodies (EBs).
After 5 days the EBs were transferred to well plates coated with
growth factor reduced Matrigel (GFRM; Corning) and cultured in
the presence of the same medium. After 7 days rosettes had
formed, which were dissociated with Dulbecco’s PBS (without
MgCl2, CaCl2)/0.1 mM EDTA into single cells and plated at a
density of 450,000 cells/cm2 on well plates coated with GFRM.
Mediumwas changed to N2B27medium (Zhu et al., 2013) supple-
mentedwith human FGF2 (20 ng/mL) andmouse EGF (10 ng/mL).
NPCs were passaged every 6 days (RP = rosette passaging number,
which indicates how often the cells have been passaged; see also
Figure S1). For Figure 1A (lower panels) NPCs were obtained using
a three-dimensional cyst-based neural differentiation protocol
published previously (Zhu et al., 2013).Immunostaining and Microscopy
NPCs were fixed in 4% paraformaldehyde in plastic- or glass-bot-
tom 24-well plates and immunostained as described previously(Zhu et al., 2013). Cells were imaged using the confocal micro-
scopes Zeiss LSM 700, LSM 710, LSM 780, and LSM 880
(103, 203, 403, and 633 objective) and the Leica DMI 4000 B
(633 objective). Confocal images are either single-stack images
or z stack images where maximum-intensity projection was per-
formed. Phase-contrast images were obtained using the Leica DM
IL. Images were processed using ImageJ, Photoshop, and Illustrator
software. A full list with all primary and secondary antibodies is
provided in Supplemental Experimental Procedures.
Statistics and Image Analysis
Image analysis was performed by using Cell Profiler and Fiji soft-
ware. For each experimental condition tested at least three inde-
pendent experiments were analyzed. From each replicate either
the number of rosettes per image (Figure 1G), the distribution of
apical rosette area (Figure 1E), number of SOX1+ cells participating
in rosette formation (Figure 1F), and the cellular apical domain size
(Figure 3G) were determined. Since the data were non-normally
distributed, the median for each replicate was determined, upon
which the mean and the SEM for each experimental condition
was calculated. For all other quantifications, mean and SEM were
determined. After checking the homogeneity of variances by the
Brown-Forsythe test, statistical comparisons were performed by
a t test or ANOVA test followed by Tukey’s a posteriori test when
comparing two conditions or more than two conditions,
respectively.
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Figure S1. Three-dimensional Dual SMAD signaling inhibition protocol. Phase contrast images of cells during 
the neural differentiation process. Related to Figure 1. (A) HESC- clumps in a non-adherent cell culture dish. 
Scale bar is 500 µm. (B) Floating embryoid bodies (EBs). Scale bar is 500 µm. (C) Plated EBs that attached to a 
6-well plate coated with growth factor reduced matrigel (GFRM, Corning). Rosette formation of EBs after 7 
days of culture. RP0 rosettes, left: low magnification image. Scale bar is 500 µm. Right: high magnification 
image. Scale bar is 50 µm. RP0 = rosette passaging number 0, indicates that the cells have not been passaged so 
far. (D) Plated EBs (same image as in Fig. S1C). (E) RP0 rosette NPCs were dissociated into single cells and 
plated at high density. NPCs (RP1) reorganize into rosettes after passaging (see arrow). RP1 rosettes were 
maintained for 5 days in N2B27+FGF2/EGF medium. Scale bar is 50 µm. RP1 = rosette passaging number 1, 
indicates that the NPCs have been passaged once. (F) Immunostaining of RP1 NPCs two days after plating for 
SOX1 and ZO-1. Scale bar is 50 µm. (G) Quantification of the total number of SOX1+ NPCs from the total 
number of cells per image. Data represent mean +/- SD, n = 3 independent experiments. DS = dorsomorphin, 
SB431542 = TGFbeta-signaling inhibitor, mTeSR1 = HESC- culturing medium. (H) Scheme depicting the 
general experimental setup for most of the experiments presented in this study. At RP0 the NPCs were passaged 
to RP1 or to RP2. Two days after plating LPA was added at different concentrations to the NPCs for a period of 
0-24 h in 0.5 ml N2B27 + FGF2/EGF medium in 24-well plates. (I) Scheme illustrating the NPC- culturing and 
passaging conditions. NPCs were plated on 24-well plates coated with GFRM and cultured in 0.5 ml of N2B27 + 
FGF2/EGF medium. Cells were passaged every 6 days into new well plates. (J) Immunostaining of NPCs at 
different passaging numbers (RP1-RP10) for SOX1 and ZO-1. Nuclei in all images were labelled with Hoechst 
33342. Scale bar is 100 µm. For a detailed description of the LPA assays see Supplemental Experimental 
Procedures. 
 
 
 
 
Figure S2. LPA-induced neural rosettes express CD133. Related to Figure 1. Z-stack images of HESC-
derived NPCs incubated with 15 µM LPA for 18 h. Distances in µm indicate the distance of the respective 
image from the plate bottom. Immunostaining for ZO-1 and CD133 (Prominin-1). Nuclei were labelled with 
Hoechst 33342. Arrows indicate small dots of CD133 expression. Scale bar is 50 µm. 
 
 
 
 Figure S3. Position of M-phase nuclei is not altered in HESC-derived- and axolotl rosette-NPCs in the presence 
of LPA. Related to Figure 2. (A) HESC-derived NPCs at RP0 (upper panels), RP2 (middle panels) and axolotl 
NPCs (lower panels) were cultured in the absence (control) or presence of LPA (+ LPA) (see Supplemental 
Experimental Procedures). HESC-derived NPCs were immunostained for ZO-1, SOX2 and phospho-Histone H3 
(pH3). Axolotl NPCs were stained for SOX2, C-cadherin and pH3. All nuclei were stained with Hoechst 33342. 
Scale bars are 100 µm (upper and lower panel) and 50 µm (middle panel). (B-D) Quantification of the relative 
frequencies of the distances from the center of the pH3+ nuclei surrounding a lumen towards the apical lumen 
site in control- and LPA-treated HESC-derived and axolotl NPCs. (B-D) Relative distances of pH3+ nuclei 
towards the lumen site of HESC-derived NPCs at RP0 (B), RP2(C) and axolotl NPCs (D). n = 3 independent 
experiments. Measured distances from control and LPA-treated replicates were pooled respectively and 
statistical analysis was performed using a u-test. 
 
 Figure S4. Time-course of the large rosette formation process of HESC-derived NPCs exposed to different 
LPA concentrations. Related to Figure 3. Immunofluorescence of NPCs that were sequentially fixed at 2 h, 10 
h, 18 h and 24 h after an initial exposure to LPA concentrations ranging from 0 – 30 µM in a media volume of 
0.5 ml reveals that the onset of large rosette formation can be shortened/extended by incubating the NPCs with 
different LPA concentrations. NPCs were stained for SOX1 and ZO1. Scale bar is 100 µm. 
  
 
Figure S5. Characterization of the neural stem cell responses to LPA. Related to Figure 4, Figure 5 and 
Discussion. (A) Testing of a Ca2+ requirement for responding to LPA.  Immunostaining of NPCs for SOX2 and 
ZO-1 that were incubated for 5 h without (control), in the presence of LPA [7.5 µM] or additionally with 2-APB 
(Abcam, Cat. No. 120124), BAPTA-AM (Abcam, Cat. No. 120503), Edelfosine (Tocris, Cat. No. 3022) and 
EGTA (VWR, Cat. No. 03779). Nuclei were stained with Hoechst 33342. Scale bar is 50 µm. (B) Quantification 
of the apical area per cell in µm2. Statistical significance was analyzed using an ANOVA test followed by a 
Tukey a posteriori test. * p < 0.05, n = 3 independent experiments (C) Constant LPA exposure maintains the 
large rosette morphology of HESC-derived NPCs. Immunofluorescence of NPCs that have constantly been 
cultured in culturing medium (control) or medium supplemented with 1 - 2 µM LPA (+ LPA) for 52 passages. 
NPCs were immunostained for SOX2 and ZO-1. Scale bar is 100 µm. (D) Constant LPA exposure prevents 
neuronal differentiation of NPCs. Immunostaining of RP1 NPCs that had been cultured in normal culturing 
medium or medium supplemented with LPA [0.5 µM] for SOX1, ZO-1 and TUBB3. All nuclei were stained 
with Hoechst 33342. Scale bar is 50 µm. (E) Metacore analysis of SRF binding targets. Experimentally known 
SRF target genes were retrieved from MetaCore using differentially expressed genes from the microarray 
analysis as input. 
 
Supplemental Experimental Procedures 
LPA assays. Related to Figure 1 – 5 and Figure S2 – S5. 
To investigate the effect of LPA on HESC-derived NPCs, cells at different rosette passaging numbers were 
treated with different concentrations of LPA or serum. Depending on the experimental setup LPA concentrations 
ranging from 0.1 µM to 30 µM or 20 % FBS were added to a volume of 0.5 ml or 2 ml medium in plastic- or 
glass bottom 24-well plates (Corning, Greiner). The applied LPA concentration for each experiment is generally 
indicated in the main text, in the figure legend of the respective figure. NPCs were exposed for different time 
periods to LPA ranging from 2 h to 36 h. NPCs shown in Figure 1, Figure 2E, Figure 3A, Figure 5A, Figure S2, 
Figure S3 (middle right panel) and Figure S4 were incubated for 2 – 24 h with different LPA concentrations in a 
volume of 0.5 ml medium. NPCs shown in Figure 3B, 3C and Figure 4O were incubated for 10 h in the presence 
of LPA in 0.5 ml or 2 ml medium. Cells shown in Figure 4C and Figure S3 (upper panels) were exposed for 8 h 
and 12 h in 2 ml medium to 10 μM and 3 μM LPA, respectively. Cells shown in Figure S5A were incubated for 
5 h with LPA in 2 ml medium. NPCs presented in Figure 4N were incubated for 10 h in 2 ml of media volume 
and 1µM LPA. Long-term exposure of the NPCs to LPA (Figure 2A, Figure 3E and 3F, Figures 5B, 5C and 5G, 
Figure S5C and S5D) was performed by incubating the cells with different LPA concentrations for several days. 
To achieve more stable LPA concentrations in the medium throughout the incubation time we increased the 
culture medium volume from 0.5 ml to 2 ml per well, thereby quadruplicating the amount of total LPA 
molecules per well to ameliorate the effects of LPA depletion and in addition, renewed the medium every 6 h 
(Figure 3E and 3F), every 12 h (Figure 2A, Figure 5C, upper and middle panels, Figure S5D) or every 24 h 
(Figure 5B, 5C, lower panels, 5G and Figure S5C). 
Fitting the two-state model to the data of apical domain size per cell. Related to Figure 3. 
We analyzed the apical domain size per cell versus LPA concentrations with a two-state model. Briefly, the 
model assumes that LPA concentration ([LPA]) drives the apical domain size from a minimal value Amin to a 
maximal value Amax, according to the following differential equation: 
𝑑𝐴
𝑑[𝐿𝑃𝐴]
= 𝑘(𝐴𝑚𝑎𝑥 − 𝐴)     (Eq. 1) 
With the initial condition: 
𝐴([𝐿𝑃𝐴] = 0) =  𝐴𝑚𝑖𝑛     (Eq. 2) 
The analytical solution is: 
𝐴([𝐿𝑃𝐴]) =  𝐴𝑚𝑎𝑥 − (𝐴𝑚𝑎𝑥 − 𝐴𝑚𝑖𝑛)𝑒
−𝑘[𝐿𝑃𝐴]  (Eq. 3) 
From Eq. 3 we calculated the [LPA] that would be necessary to achieve the 50 % of the difference between the 
maximal and the minimal apical domain size per cell ([LPA]50) as follows: 
[𝐿𝑃𝐴]50 = ln ((
1
2
)
1
𝑘
)      (Eq. 4) 
We fitted a two-state model to the experimental data (Figure 3G) and found that [LPA]50 is 0.766 μM, a 
concentration that is in agreement with the range of physiological LPA concentrations present in serum (Yung et 
al., 2014). 
 
Primary antibodies used in this study. Related to Figure 1 – 5 and Figure S1-S5. 
goat anti-SOX1 (1:100, R&D Systems), goat anti-SOX2 (1:100, R&D Systems), mouse anti-SRF (1:100, Merck 
Millipore), rabbit anti-N-cadherin (1:100, Santa Cruz Biotechnology), rabbit anti-PKC (1:100, Santa Cruz 
Biotechnology), mouse anti-ZO-1 (1:150, BD Biosciences), rabbit anti ZO-1 (1:100, Thermo Fisher Scientific), 
rabbit anti-Vimentin (1:500, Abcam), rabbit anti-Nestin (1:500, Abcam), mouse anti-Prominin-1 (1:25, Miltenyi 
Biotec), mouse anti-betaIII-tubulin (TUBB3, 1:700, R&D Systems), mouse anti-GFAP (1:500, Merck 
Millipore), mouse anti-HuC/HuD (1:50, Thermo Fisher Scientific), rabbit anti- active Caspase 3 (1:800, Abcam), 
rabbit anti-phospho histone H3 (1:400, Merck Millipore), mouse-anti c-cadherin (1:20, DSHB).   
Secondary antibodies used in this study. Related to Figure 1 -5 and Figure S1-S5. 
Secondary antibodies used in this study were as follows: Alexa Fluor 488 donkey anti-rabbit IgG (1:200, 
Invitrogen), Alexa Fluor 647 donkey anti-mouse IgG (1:200, Invitrogen), Cy3- donkey anti-goat IgG (1:100, 
Dianova). Nuclei were stained with Hoechst 33342 (1-5 μg/ml, Sigma). F-actin staining was performed by 
adding Alexa Fluor 488 Phalloidin (1:200, Invitrogen). Phalloidin was added for 30 minutes to the cells and 
removed together with the secondary antibodies. 
Microarray analysis and GO term functional annotation clustering of upregulated genes. Related to 
Figure 4.  
RNA from three independent experiments was used to perform Agilent One-Color Microarray-Based Gene 
Expression Analysis (version 6.5) according to the manufacturer's instructions (Agilent Technologies). Briefly, 
for each sample 90 ng total RNA (derived from RP2 control small-rosette NPCs and NPCs treated with 25 µM 
LPA) was used to reverse transcribe double stranded cDNA and subsequently in-vitro transcribe Cy3-labeled 
target cRNA with the Low Input Quick Amp Labeling Kit (Agilent Technologies). The target cRNAs were 
hybridized to SurePrint G3 Human GE 8×60K Microarrays (AMADID 039494, Agilent Technologies). Scanned 
images were analysed with the Feature Extraction software 10.7.1.1 (Agilent Technologies) using default 
parameters (protocol: GE1_107_Sep09, grid: 039494_D_F_20120628) to obtain background-corrected signal 
intensities. The data were further analysed with the GeneSpring GX Software (Version 13.0, Agilent 
Technologies), where quantile normalization of the data and removal of unreliable signal intensities (filtering of 
data by expression: in three out of six experiments the signal intensity of a probe had to be above the 20th 
percentile to be retained in the data set) were performed. For statistical analysis a one-way ANOVA analysis 
with a p-value cutoff of 0.05 was performed. Gene ontology (GO) functional annotation clustering of the genes 
which were significantly up- or downregulated (> two-fold) in the presence of LPA was performed using 
DAVID software (https://david.ncifcrf.gov/, version 6.8). For functional annotation clustering the GO cellular 
component database (GO_CC_all) was used. Analysis classification stringency was set to medium. The 
microarray data shown in this paper have been uploaded to the Gene Expression Omnibus (GEO) database 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111597). 
Measurement and blockage of cell proliferation. Related to Figure 2. 
For measurement of the proliferative activity of the cells, NPCs were incubated for 45 min with 30 μM 5-
ethynyl-2’-deoxyuridine (EdU) prior to fixation. EdU was detected by the Click-iT® Alexa Fluor 488 imaging 
kit (Invitrogen). The procedure was performed according to the manual´s instructions. Cell proliferation was 
blocked using hydroxyurea (HU) (Sigma-Aldrich). NPCs were incubated for 12 and another 18 h with 0.5 µM 
HU in medium or medium supplemented with LPA. 
